Target intelligence / Profile preview

Microtubule dynamics disruption

Molecular classification
Other (Process affecting cytoskeletal proteins, especially "Tubulin modulators")
01

Overview

Microtubule dynamics disruption refers to interference with the normal polymerization and depolymerization of microtubules—cytoskeletal filaments essential for cell division, intracellular transport, and maintenance of cell shape. This process is the pharmacological target of several anti-cancer drugs, as rapidly dividing cells (such as cancer cells) rely on precise control of microtubule dynamics for proper mitosis. Drugs targeting microtubule dynamics either stabilize microtubules (e.g., taxanes) and prevent depolymerization or destabilize them (e.g., vinca alkaloids, colchicine), leading to cell cycle arrest and apoptosis of proliferating cells. Targeting this process is clinically important but presents safety concerns, especially regarding neurotoxicity and resistance. This entry is not a valid molecule/receptor for structured target annotation, but describes a pharmacological strategy used in modern therapeutics.

Other names
Microtubule destabilizationMicrotubule stabilizationTubulin polymerization inhibitionTubulin dynamics interference
02

Mechanism of action

Microtubule stabilization (prevents depolymerization; e.g., taxanes like paclitaxel) Microtubule destabilization (prevents polymerization or enhances depolymerization; e.g., vinca alkaloids, colchicine)

03

Biological functions

Cell division (mitosis, meiosis)Cell cycle progressionIntracellular transportCell migration and motility
04

Disease associations

CancerNeurodegenerative diseaseInflammationOther (generally any disease involving cell proliferation or cytoskeletal abnormalities)
05

Safety considerations

Neurotoxicity (peripheral neuropathy)MyelosuppressionResistance mechanisms (upregulation or mutation of tubulin, drug efflux transporters)Non-specific cytotoxicity (effects on non-dividing cells)
06

Interacting drugs

Paclitaxel (Taxol)

5 more in the full profile.

07

Biomarkers

Tubulin expression levelsβIII-tubulin isoformMitotic index in tumor samples

Beyond the preview

Go deeper on Microtubule dynamics disruption.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microtubule dynamics disruption.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call